NCT07009249 Dynamic Neuromuscular Stabilization Exercises in Women With Urinary Incontinence
| NCT ID | NCT07009249 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Izmir University of Economics |
| Condition | Stress Urinary Incontinence (SUI) |
| Study Type | INTERVENTIONAL |
| Enrollment | 62 participants |
| Start Date | 2025-05-21 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 62 participants in total. It began in 2025-05-21 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Stress urinary incontinence (SUI) is defined by the International Continence Society as the complaint of involuntary leakage of urine during physical exertion, including sports activities, or during sneezing or coughing. In continent women, an automatic response-namely, a reflex pelvic floor muscle (PFM) contraction, also known as pre-contraction-occurs either prior to or during physical exertion. Although there is strong evidence supporting the effectiveness of pelvic floor muscle training (PFMT) in the treatment of SUI, there has been a growing interest in exploring alternative exercise-based interventions. Dynamic Neuromuscular Stabilization (DNS) is a manual and rehabilitative approach developed by Professor Pavel Kolar. It is grounded in the scientific principles of developmental kinesiology and aims to optimize the function of the movement system. Currently, DNS is successfully employed in the rehabilitation of various neurological, musculoskeletal, pediatric, and sports-related injuries. DNS incorporates the subconscious and synergistic activation of the deep core muscles responsible for intra-abdominal pressure (IAP) regulation and spinal stability-namely, the diaphragm, transversus abdominis, multifidus, and pelvic floor muscles-as well as the global musculature. Considering the potential mechanisms of DNS, we hypothesize that DNS exercises, through IAP regulation directed toward the pelvic cavity and contributing to stabilization, could serve as an effective and innovative approach for women with SUI. The hypotheses of this study are as follows: H1.1: DNS is as effective as PFMT in reducing urinary symptoms in women with SUI. H1.2: DNS is as effective as PFMT in improving PFM function in women with SUI.
Eligibility Criteria
Inclusion Criteria: * Female gender, * Voluntary participation in the study, * Aged between 18 and 62 years, * Ability to read and write in Turkish, * No mental disorders that would impair cooperation or comprehension, * Complaint of stress urinary incontinence (SUI) or stress-predominant mixed urinary incontinence. Exclusion Criteria: * Prior history of pelvic floor muscle training, * Presence of any neurological disorder, * Pelvic organ prolapse stage II or higher, * Presence of fecal incontinence, * Pregnancy, * Lower extremity conditions that may affect pelvic alignment (e.g., leg length discrepancy, total hip arthroplasty), * Active lower urinary tract infection, * Presence of respiratory disorders such as chronic obstructive pulmonary disease or asthma, * History of hysterectomy.
Contact & Investigator
Seda Yakıt Yeşilyurt
PRINCIPAL INVESTIGATOR
Izmir University of Economics
Frequently Asked Questions
Who can join the NCT07009249 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 62 Years, studying Stress Urinary Incontinence (SUI). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07009249 currently recruiting?
Yes, NCT07009249 is actively recruiting participants. Contact the research team at sedayakit01@gmail.com for enrollment information.
Where is the NCT07009249 trial being conducted?
This trial is being conducted at Izmir, Turkey (Türkiye).
Who is sponsoring the NCT07009249 clinical trial?
NCT07009249 is sponsored by Izmir University of Economics. The principal investigator is Seda Yakıt Yeşilyurt at Izmir University of Economics. The trial plans to enroll 62 participants.